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In Poland, as in other countries, increasing
bacterial pathogens resistance occurs (1-4). This
process is, to a large degree, linked with excessive,
often ungrounded prescription of antibiotics (5).
The Polish National Health Fund (NHF) ñ a health
insurance organization which is the major public
source of health care financing ñ records a continu-
ous increase of spendings on antibacterial treatment
(6). This problem is of interest to specialists of mul-
tiple health care disciplines (7, 8). It is also reflect-
ed in numerous publications attempting to present
quantitative and qualitative trends in the use of
antibiotics in treatment of different diseases (9, 10).
These publications provide information about the
level of utilization of these drugs, seasonal varia-
tions and long term trends in antibacterial pharma-
cotherapy using defined daily dose (DDD) method-
ology.
Available studies have been based on a few
basic types of data of varying reliability: including
survey data, data provided by companies analyzing
the pharmaceutical market, insurance companies
wholesale reports, as well as hospitalsí and pharma-
ciesí records. These sources provide general infor-
mation referring to populations of entire countries or
regions. There is a lack of an in-depth analysis of
antibiotics utilization pattern within studied popula-
tions. This probably stems from the difficulty in
acquiring reliable data which would fully describe
drug consumption in a large, strictly-defined popu-
lation (11). Thus, two aspects remain unidentified,
the first one being the level of consumption of
antibiotics and its seasonal variations in different
age groups, the other one being identification of the
patient population having the key influence on the
drug reimbursement system, in relation to antibac-
terial pharmacotherapy. There is also a lack of stud-
ies presenting the relation between drugs for
obstructive airway diseases consumption and
antimicrobial therapy frequency.
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Abstract: The goal of this study was to analyze antibacterial drug prescribing in the 1-million-plus, strictly
defined population in Poland. For the 2002-2005 years, data from National Health Fund on outpatient purchas-
ing of antibiotics in Lubuskieís Province were collected and expressed in DDD per 1-thousand inhabitants per
day (DID). In the period 2002-2005 the average rate of antibiotics purchasing was 19.8 DID. During the 3-year
period, at least 64.3% of the population had prescribed antibiotics. 22.7% of patients purchased 62.6% of a
three-year total purchasing of antibacterial drugs in the province. A tiny 1.9% of the population purchased
10.0% of the total. From the different age-group, the study showed that special attention should be paid to two
different and relatively small groups of patients ñ those utilizing significant percentage of the yearís supply, and
group of 5-9 year-old children. Seasonal variation in antibiotic prescribing was strictly linked with the age of
patients. Pulmonary diseases were indentified as a factor considerably elevating antibacterial drugs purchasing
frequency. A useful way to present recurring patterns in this frequency has been proposed.
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The goal of this study was to analyze a pre-
scription pattern of antibacterial drugs, based on
data from a large, age-defined population of the
Lubuskieís Province in Poland. We have showed the
relation between the antibacterial drugs use, the fre-
quency of ambulatory treated infectious diseases,
and the age of the patients. The unique character of
the available data has allowed to create a map repre-
senting the frequency of the antibacterial therapy.
Methods
Data
The following sources of information were
used during the study: the data from the Lubuskieís
Regional Unit of the NHF (12) and the demograph-
ic data from the Central Statistical Office (GUS)
(13).
The regional units of the National Health Fund
gather information about the sales volume of the
reimbursed drugs in order to refund the money to
pharmacies. In the Lubuskieís Province, the collect-
ed data included a PESEL, a unique number for each
Polish citizen, identifying among others the age of
each patient who has been prescribed a drug. This
allows tracking the reimbursed drugs Sales
Operation (SO) in relation to every individual
patient. 
Data from the NHF (approximately 25 million
records) ñ each one corresponding to a single sale
of a reimbursed drug in a pharmacy (SO) ñ were
used. SO of reimbursed drugs has been recorded
for 975.6 thousand patients during the study peri-
od. Of the NHF records, 3.2 million refer to the
antibacterial for systemic use (J011). Finally the
study database consisted of 3.034 million records
(SO), corresponding to 699.7 thousand patients.
The rest of the records were deleted during prepro-
cessing due to technical reasons. Within the study
population 86.7 thousand patients were recognized
as treated with drugs for obstructive airway dis-
eases (R031). They were divided into two groups,
according to intensity of drug therapy ñ Patients
Occasionally Treated (POT) and Patients
Extensively Treated (PET), the groups comprising
72.5 and 14.2 thousand patients, respectively ñ
methodology described elsewhere (14).
According to the demographic data, the ana-
lyzed population consisted of 1.009 million inhabi-
tants ñ this value did not change by more than 0.1%
in the study period.
The data used in the study, in spite of different
methods of collection, and a potential information
processing error, were compatible with official pub-
lications of the National Health Fund (15). What
draws attention, after juxtaposing the structure of
consumption with the data from the whole of
Poland, is a lower use of furazidin and cefuroxime in
the Lubuskieís Province. The population of the
Lubuskieís province exhibits antibiotics consump-
tion about 5% lower than the national average (16).
Taking this into consideration the data were estimat-
ed as representative for the whole country. 
The presentation of the results is based on the
ATC/DDD classification systems (WHO,
ATC/DDD version 2006) (17) and expressed in
DDD per 1000 inhabitants per day (DID) as well as
percentage of total drugs consumption (% DDD).
The results referring explicitly to the sales operation
(SO) were expressed in SO per 1000 inhabitants per
day (SOID) as well as in the percentage of SO (%
SO).
The results were rounded up to the first digit
after the decimal point. Microsoft Office software as
well as Statistica for Windows v. 6.0 (StatSoft,
Poland), and the SPSS v.14 (SPSS Inc.) packages
were used.
Terms used
Sale operation (SO) ñ refers to every single pur-
chase of an antibacterial drug by a patient. 
Antibiotic therapy course (ABC) ñ refers to a single
case of purchase of an antibacterial drug by a
patient, each case being separated by a 30-day peri-
od of time from one to another. If in the defined
period more than one event of an antibacterial drug
sale occurred, it was treated as belonging to one
course.
Recurrent course of antibiotic therapy (RABC) ñ
refers to at least one event of purchase of an anti-
bacterial drug by a patient in the 6 succesive 6-
months-subperiod from August 2002 to July 2005.
Patients were classified to the appropriate RABC
group (1-6) according to the number of subperiods
in which they have purchased a drug.
RESULTS
The average level of antibiotics purchasing
(2002-2005) was 19.8 DID in the population of the
Lubuskieís province. School age patients (5-19
1 Anatomical Therapeutic Chemical (ATC) classification system (17)
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year-old), as well as people aged 60-year or older,
rank above the average of DID (Figure 1). The max-
imum deviation from the estimated average was
observed for the oldest patients (over 75 year-old).
The analysis based on the criterion of registered SO
and the quantity of dispensed packages of drugs
revealed that 20-59 year-old patients are character-
ized by a stable average of SO, equal to 1.6 SOID
(Figure 2). The amount of SO gradually rose with
the age of patients and reached the level of 3.1 SOID
for patients over 80 years old. The highest amount of
SO was recorded for patients below 10 years old
(5.4 SOID in a group of patients below age of 4).
Using the accumulated data (not presented on
Figure), it was observed that the age group 0-9
years, while constituting only 10.2% of the popula-
tion, generated 23.6% of all recorded SO, whereas
the group of the oldest patients (65 year olds plus),
amounting to 11.6% of the population, generated
13.9% of total amount of the recorded SO.
The estimated seasonal antimicrobial drug pur-
chasing fluctuations (for the Lubuskieís province
population as a whole) (Figure 3) follow the pattern
described in other publications (2, 18). The patient
population was not homogenous in terms of the sea-
sonal changes concerned. In all age groups, the
Figure 1. Average yearly antibiotics consumption in different age groups. The average consumption level in the analyzed population was
19.8 DDD/1000 inhabitants/day (DID) ñ dotted line. Percentage values indicate deviation from average consumption in different age
groups. Based on 1.009 million population.
Figure 2. Average yearly antibiotics SO in different age group. The average consumption level in the analyzed population was 2.2 SO/1000
inhabitants/day (SOID) ñ dotted line. Percentage values indicate deviation from average SO in different age groups. Presented data are
almost equal with amount of dispensed packages of drugs (packages/1000 inhabitants/day). Based on 1.009 million population.
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months of the largest purchasing were December
and March, whilst the lowest level was recorded in
the summer months of June, July and August. There
was a significant peak of purchasing for the
youngest patients (0-4 years old) at the beginning of
the winter season (December), when the sales of
antibiotics were 3.7 times higher than in August,
which was the month of the lowest purchasing.
There was tendency for two purchasing peaks for
children aged 5-9 in the months of December and
March. It was 3.8 and 4.0, respectively, times high-
er than in the lowest purchasing months. Patients
aged 10-19 showed a significant peak of consump-
tion in March (5.5 times higher than in July;
(222.7% of average yearly consumption). The sea-
sonal values curve shows a strong tendency to be
flatter for the older age groups. Patients who were
20 years old or more, had a single peak incidence in
March, when the level of purchasing was 2.4 times
higher than in August (the lowest purchasing during
the year March +52.1%; August ñ36.1% of the aver-
age this age group purchasing).
The incidence of ambulatory treated infectious
diseases was based on Antibiotic Therapy Courses
(ABC) (Figure 4). The average yearly incidence of
ABC for patients in the age group 20-59 was 30.2%
rising to 48.3% for the eldest patients (over 75 year-
old). The maximum of ABC was recorded for the
age group 5-9 (67.2%).
The DDD methodology was used to estimate
the size of the high consumption group. In every
calendar year, at least one SO was recorded for an
average of 38.2% of Lubuskieís Province popula-
tion (385.0 thousand patients). These number con-
stitutes a yearly-treated population (YTP) (Figure
5). 10% of that population purchased 30.9% DDD of
the total antibiotics consumption whereas 50%,
characterized by the lowest consumption level, used
only 20.9% DDD of these medications (Figure 5).
The number of Recurrent Antibiotic Therapy
Courses (RABC) for particular patients was calcu-
lated for a 36-month period, divided into 6-month
subperiods. At least one purchase of an antibiotic in
each of the succesive subperiod was recorded as a
RABC (see terms used). 6-month subperiods were
used in order to facilitate comprehension ñ raw data
were available daily. Medical visits resulting in the
Table 1. 36-month incidence of Recurrent Antibiotic Therapy
Courses (RABC) of the Lubuskieís province inhabitants.
Comparison of antibiotics use (DDD methodology) and the num-
ber of SO during 36-month analysis period in different groups of
patients corresponding to RABC classification. Based on 1.009ñ
million population.
Number of % of % of
RABC patients1 DDD2
% of SO3
6 1.9 10.0 12.1
5 3.7 13.8 15.2
4 6.5 17.8 18.2
3 10.6 20.9 20.1
2 17.4 21.8 20.2
1 24.2 15.5 14.1
0 35.7 0 0
1 Population size 1.009 million people
2 Total consumption 23.69 million DDD
3 Total Sales Operations 2.74 million SO 
Figure 3. Comparison of seasonal variations in consumption of antibiotics in different age groups. Percentage deviations from yearly aver-
age were calculated separately in every age group and for the whole population. Based on 1.009 million population.
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prescription and subsequent purchase of an antibac-
terial drug were recorded during the 36-month ana-
lyzed period for 63.4% of Lubuskieís Province pop-
ulation (Table 1). Solely 1,9% of population pur-
chased 10% of the total three year antibacterial
drugs purchasing. 
Comparing the yearly data of consecutive year
to the 3-year data, it was observed that 10% of the
most frequently, or most severely ill patients pur-
chased 59,6% DDD and 35,2% DDD of a total pur-
chasing of antibacterial drug, respectively.
Age distribution in different RABC group var-
ied. In 5 and 6 RABC category 44.8% of patients
were below 15 years old. 5-9 year old group was a
dominant population in those categories. It was very
characteristic that the oldest patients have very sta-
ble, high contribution in every disease recurrence
group (Figure 6).
Belonging of the subject to the population
treated with drugs for obstructive airway diseases
was a strong factor implicating frequency of anti-
bacterial drugs purchasing. These patients constitut-
ed 33% of total RABC-6 subpopulation; the above
mentioned percentage showed stable tendency to
decrease among lower RABC groups: from 5 to 1. 
The comparison between two groups of POT
and PET patients in combination with the RABC
factor, showed significant change in antimicrobial
drugs purchasing among more intensively treated
patients. Histogram analysis revealed that 43% of
PET and 31% of POT patients belonged to the 4, 5
and 6 RABC-group population (Figure 7). There
Figure 4. Yearly percentage of patients treated with antibacterial drugs in different age groups. Average data for 2002-2005 periods. Based
on 1.009 million population.
Figure 5. Average percentage of antibiotics consumption purchasing by successive 10% group of one year treated population (YTP).
Patients were set in order of increasing yearly antibiotics consumption, then divided into 10 equal groups (every 38.543 thousand treated
patients). Average data for every one year period (2002-2005) in DDD. Based on 1.009 million population.
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were two factors identified, namely diagnosed
obstructive pulmonary disease and drugs for
obstructive airway diseases usage, which influenced
the antibacterial drug purchase.
DISCUSSION
We would like to divide the discussion for two
parts; methodological and descriptive. Taking under
consideration usefulness of the DDD methodology it
may be stated that it provides unquestionable advan-
tages in studies of drug use, ensuring the compara-
bility of the analyses made in different countries and
by different researchers. Despite its advantages, the
DDD methodology, as reported in numerous publi-
cations, fails to accurately describe drug consump-
tion in children. In the presented study, in the DDD
methodology differentiation of consumption in dif-
ferent age groups does not exceed 48.9% deviation
(the oldest patients) from the average for the studied
population. Whereas, using the number of purchased
medication packages or the frequency of the SO as
the consumption indicator methodology, one can
observe 139.8% deviation in the youngest group (0-
4 years old). 
These observations were corroborated by the
analysis of the yearly variations of antibiotics con-
sumption in different age groups. In the case of
young patients, their caretakers expect a quick
recovery from the infection and the doctors are
under pressure to prescribe an antibacterial drug. A
very significant increase of antibiotic prescriptions
Figure 6. Patients age histograms for different Recurrent Antibiotic Therapy Courses group (according to Chart 6). Based on 1.009 million
population.
Figure 7. Two groups of patients ñ occasionally (POT) and extensively (PET) treated ñ stratification between different Recurrent Antibiotic
Therapy Courses (RABC) groups populations.
Antibacterial drug prescription for outpatients: age, seasonal and pulmonary disease dependency 397
in periods of epidemic viral infections among the
youngest patients, as well as school children, shows
that the potentially most effective target groups for
educational actions were their parents, caretakers
and doctors (8).
The two key points of the study were the analy-
sis of the consumption level in a one-year periods
and creation of a useful way showing the infectious
disease incidence in a 36-month period in a large,
closed population (Table 1). We demonstrated that a
group constituting 20.9% of population was respon-
sible for the use of 62.6% of a three year supply of
antibiotic therapy in the province. Notably, it was
possible to isolate 1.9% of the population which
used over 10% of the supplies and showed an almost
chronic use of antibiotics. It is worth to mention that
this group encompassed two different subpopula-
tions ñ children in pre-school and primary school
age and, the oldest people with significantly high
level of drugs for obstructive airway diseases. In
general, the existence of a particularly frequently
treated group, might be related to therapeutic errors,
the identification of which will trigger actions aim-
ing to rationalize the treatment to be taken. Creation
of the incidence map is, in the authorsí opinion, their
unique contribution to the knowledge of antibacter-
ial drug consumption. Creating comparable studies
in populations from different countries, as well as
the possibility of observing timelines in this disci-
pline, would facilitate to draw broader conclusions
concerning the health of the society.
The data collected by payers of the health sys-
tem is a very important source of information for
pharmacoepidemiological studies. The fact that the
payerís (NHF) is centralized with most antibiotics
eligible for reimbursement, is crucial to the actions
that need to be taken. Being centralized, NHF is able
to carry out reliable analysis of the health care sys-
tem. We are conscious of some bias in the sources,
which limited our study. The system of reimbursed
treatment encompasses most of the J01 drugs regis-
tered in Poland (98%), but not 100%. 
During the period of the study, the main differ-
ences as far as drug inclusion into the system of
refunded treatment was concerned, occurred in two
groups: J01E (sulfonamides and trimethoprim) and
J01M (quinolone antibacterials) of the ATC system.
Most of the antibiotics which were excluded from the
refunded treatment system belong to these two groups. 
The data concerning consumption of the drugs
belonging to these therapeutic groups might not
reflect the actual total consumption. The underesti-
mation error might apply to patients who made only
one purchase of a drug from the ATC J01 group dur-
ing the period of the study, and is strictly linked to
the data preprocessing methodology. The weakness
of the information from the insurance systems is a
lack of information about drugs outside of the reim-
bursement system (patients without insurance, drug
sale within the pharmaceutical prescriptions). 
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